Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Tapentadol Immediate-Release Formulation in the Treatment of Acute Pain From Bunionectomy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Jul 2017
Price :
$35
*
At a glance
- Drugs Tapentadol (Primary)
- Indications Pain
- Focus Therapeutic Use
- Sponsors Janssen-Cilag
- 05 Feb 2014 Status changed from recruiting to completed according to ClinicalTrials.gov record.
- 09 Apr 2013 Status changed from suspended to recruiting as reported by ClinicalTrials.gov
- 26 Mar 2013 New trial record